Fifth Third Bancorp
MIRA icon

Fifth Third Bancorp’s MIRA Pharmaceuticals MIRA Stock Holding History

Fifth Third Bancorp’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.4K Hold
20,000
– – ﹤0.01% 3473
2025
Q4 		$30.2K Buy
+20,000
New +$29.4K ﹤0.01% 1703

Other funds holding MIRA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CSI
Cross Staff Investments Pittsford, New York $197M AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Fifth Third Bancorp's MIRA Position: Q1 2026 in Review

Fifth Third Bancorp held its MIRA Pharmaceuticals (MIRA) position steady in Q1 2026 at 20,000 shares worth $21.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3473.

Fifth Third Bancorp first reported a position in MIRA in Q4 2025 and has held it in 2 quarters since. The position peaked at $30.2K in Q4 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q1 2026.

  • Fifth Third Bancorp held 20,000 shares of MIRA Pharmaceuticals worth $21.4K as of Q1 2026.
  • Fifth Third Bancorp left its MIRA Pharmaceuticals share count unchanged in Q1 2026.
  • MIRA Pharmaceuticals made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #3473 holding.
  • Fifth Third Bancorp first reported a position in MIRA Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Fifth Third Bancorp's MIRA Pharmaceuticals position peaked at $30.2K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.